Your browser doesn't support javascript.
loading
GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide.
Parik, Sweta; Fernández-García, Juan; Lodi, Francesca; De Vlaminck, Karen; Derweduwe, Marleen; De Vleeschouwer, Steven; Sciot, Raf; Geens, Wietse; Weng, Linqian; Bosisio, Francesca Maria; Bergers, Gabriele; Duerinck, Johnny; De Smet, Frederick; Lambrechts, Diether; Van Ginderachter, Jo A; Fendt, Sarah-Maria.
Afiliação
  • Parik S; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
  • Fernández-García J; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Lodi F; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • De Vlaminck K; Myeloid Cell Immunology Laboratory, VIB Center for Inflammation Research, Brussels, Belgium.
  • Derweduwe M; Laboratory of Cellular Metabolism and Metabolic Regulation, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
  • De Vleeschouwer S; Laboratory of Cellular Metabolism and Metabolic Regulation, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Sciot R; Laboratory for Translational Genetics, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
  • Geens W; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.
  • Weng L; Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium.
  • Bosisio FM; Myeloid Cell Immunology Laboratory, VIB Center for Inflammation Research, Brussels, Belgium.
  • Bergers G; Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging & Pathology, KU Leuven, Leuven, Belgium.
  • Duerinck J; Department of Neurosurgery, University Hospital Leuven, Leuven, Belgium.
  • De Smet F; Department of Pathology, University Hospital Leuven, KU Leuven, Leuven, Belgium.
  • Lambrechts D; Department of Neurosurgery, UZ Brussel, Jette, Belgium.
  • Van Ginderachter JA; Laboratory of Tumor Microenvironment and Therapeutic Resistance, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
  • Fendt SM; Department of Pathology, University Hospital Leuven, KU Leuven, Leuven, Belgium.
Front Oncol ; 12: 988872, 2022.
Article em En | MEDLINE | ID: mdl-36338708
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica